Study concludes VISIA CR imaging can automate acne evaluation for treatments and clinical studies
A recent study published in the July issue of the "Journal of Drugs in Dermatology" evaluates the effectiveness of the VISA CR in counting and classifying acne lesions. "Auto-Classification of Acne Lesions Using Multimodal Imaging" shows a high degree of correlation between evaluations performed manually a physician, and those performed automatically using VISIA CR imaging technology. The peer reviewed article based on this study was a collaborative effort between researchers from Canfield Scientific, Inc and the Proctor & Gamble Company.
The study concludes that "This technology has the potential to eliminate the tedium of manual lesion counting, and provide an accurate, reproducible, and clinically relevant evaluation of acne lesions. As an aid to physicians it will allow development of a standardized technique for evaluating acne in clinical research, as well as accurately choosing treatment options for their patients according to the severity of a specific lesion type in clinical practice."
Recent News in Announcements
- VISIA®’s 5th Consecutive Win as Favorite Diagnostic Tool in Dermascope’s Aestheticians’ Choice Awards!
- The first VECTRA® WB360 whole-body imaging system in Vietnam has been installed at Dr. Hoàng Tuấn Medical, Plastic & Aesthetic Surgery Group
- Canfield Scientific is Working with iToBoS to Develop Next Generation Artificial Intelligence
- VECTRA® WB360 whole-body imaging system, donated by The Carolina Zani Melanoma Foundation ETS, installed in Spedali Civili Di Brescia